Search

everythinglearnresearchcommunity

for

Search:↓

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Topical glycopyrrolate lotion helped reduce excessive sweating from eating in a diabetic man.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Dutasteride may protect the brain in early Parkinson's disease.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Finasteride reduces movement issues in Parkinson's disease rats.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Dutasteride is approved to help manage prostate enlargement.